{"id":"radiopharmaceutical-18f-jk-psma-7","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL4650355","moleculeType":"Small molecule","molecularWeight":"989.97"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This radiopharmaceutical is a diagnostic imaging agent designed to target PSMA, a transmembrane protein highly expressed on prostate cancer cells. The fluorine-18 radiolabel enables PET imaging to detect and localize PSMA-positive lesions, facilitating tumor staging, restaging, and treatment planning in prostate cancer patients.","oneSentence":"18F-JK-PSMA-7 is a fluorine-18 labeled radiopharmaceutical that binds to prostate-specific membrane antigen (PSMA) for positron emission tomography (PET) imaging of PSMA-expressing tumors.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:31:09.652Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"PET imaging of PSMA-positive prostate cancer"}]},"trialDetails":[{"nctId":"NCT05622162","phase":"PHASE3","title":"Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7","status":"ACTIVE_NOT_RECRUITING","sponsor":"ITEL Telecomunicazioni Srl","startDate":"2022-12-19","conditions":"Prostate Cancer, 18F- Fluorocholine, PSMA PET","enrollment":106}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":6,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["18F-JK-PSMA-7"],"phase":"phase_3","status":"active","brandName":"Radiopharmaceutical 18F-JK-PSMA-7","genericName":"Radiopharmaceutical 18F-JK-PSMA-7","companyName":"ITEL Telecomunicazioni Srl","companyId":"itel-telecomunicazioni-srl","modality":"Small molecule","firstApprovalDate":"","aiSummary":"18F-JK-PSMA-7 is a fluorine-18 labeled radiopharmaceutical that binds to prostate-specific membrane antigen (PSMA) for positron emission tomography (PET) imaging of PSMA-expressing tumors. Used for PET imaging of PSMA-positive prostate cancer.","enrichmentLevel":3,"visitCount":2,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}